Study guide
3.1 Cancer, Hematologic, and Paraneoplastic Complications
Certified Hospice and Palliative Nurse CHPN
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Fees, Windows, and Retakes 1.3 Scoring, Test-Day Rules, and Remote Proctoring 1.4 Recertification: HPAR and the Situational Judgment Exercise
2 Chapter 2: Assessment, Goals, and Care Planning
2.1 Goals of Care and Shared Decision Making 2.2 Interdisciplinary Care Planning and Ongoing Evaluation 2.3 Prognostic and Functional Assessment Tools 2.4 Levels of Care and Care-Setting Transitions
3 Chapter 3: Life-Limiting Disease Progression I
3.1 Cancer, Hematologic, and Paraneoplastic Complications 3.2 Heart Failure and Cardiac Disease Progression 3.3 Pulmonary Disease Progression 3.4 Neurologic Disease Progression
4 Chapter 4: Disease Progression II and Imminent Death
4.1 Dementia, Frailty, and Feeding Decisions 4.2 Renal, Hepatic, and Endocrine Trajectories 4.3 Indicators of Imminent Death
5 Chapter 5: Pain Assessment
5.1 Pain Types, Etiology, and Syndromes 5.2 Verbal and Nonverbal Pain Assessment and Scales 5.3 Factors That Influence the Pain Experience
6 Chapter 6: Pharmacologic Pain Management
6.1 Opioid and Non-Opioid Analgesics by Pain Type and Severity 6.2 Adjuvant Analgesics 6.3 Titration, Baseline Dosing, and Breakthrough Pain 6.4 Equianalgesic Conversion and Route Changes
7 Chapter 7: Nonpharmacologic Pain and Opioid Safety
7.1 Nonpharmacologic Pain Interventions 7.2 Complementary and Integrative Pain Therapies 7.3 Opioid Adverse Effects, Neurotoxicity, and Rotation
8 Chapter 8: Neurological, Cardiovascular, and Respiratory Symptoms
8.1 Neurological Symptoms 8.2 Delirium and Terminal Restlessness 8.3 Cardiovascular Symptoms 8.4 Respiratory Symptoms: Dyspnea, Cough, and Secretions
9 Chapter 9: Gastrointestinal, Genitourinary, and Musculoskeletal Symptoms
9.1 Gastrointestinal Symptoms 9.2 Genitourinary Symptoms 9.3 Musculoskeletal Symptoms
10 Chapter 10: Skin, Metabolic, Hematologic, and Psychospiritual Symptoms
10.1 Skin and Mucous Membrane Symptoms 10.2 Nutritional and Metabolic Symptoms 10.3 Immune and Hematologic Symptoms 10.4 Psychosocial, Emotional, and Spiritual Symptom Burden
11 Chapter 11: Advance Care Planning, Benefits, and Safety
11.1 Advance Care Planning and Life-Sustaining Therapies 11.2 Hospice and Palliative Benefits under Medicare, Medicaid, and Private Insurance 11.3 Patient Safety: Environmental, Physical, and Socioemotional
12 Chapter 12: Communication, Culture, and Psychosocial Support
12.1 Communication Techniques, Barriers, and Family Meetings 12.2 Cultural Humility and Spiritual Needs 12.3 Psychosocial Needs and IDG Participation
13 Chapter 13: Caregiver Education and Medication Management
13.1 Medication Management and Controlled Substances 13.2 Caregiver and Family Self-Care 13.3 Teaching End-Stage Disease, Pain, and Symptom Plans 13.4 Caregiver Skills, DME, Supplies, and Services
14 Chapter 14: Grief, Death, and End-of-Life Ethics
14.1 Grief, Loss, and Bereavement 14.2 Support at the Time of Death and Post-Mortem Care 14.3 Ethical Issues Related to End of Life
15 Chapter 15: Medicare Hospice Compliance and National Standards
15.1 Medicare Hospice Benefit and Conditions of Participation 15.2 Hospice Eligibility, Admission, and Recertification 15.3 National Hospice and Palliative Care Standards 15.4 National Consensus Project Clinical Practice Guidelines
16 Chapter 16: Legal, Professional Practice, Quality, and Policy
16.1 Legal Regulations: CMS, HIPAA, and OSHA 16.2 Professional Boundaries and Ethics 16.3 QAPI, Self-Care, and Precepting 16.4 Policy, Delivery, and Reimbursement Trends
3.1 Cancer, Hematologic, and Paraneoplastic Complications
Key Takeaways Explain This Topic AI
Solid-tumor hospice trajectories often hold function for months, then fall steeply in the last weeks; hematologic cancers are less linear because infection, cytopenias, and treatment toxicity can collapse status overnight.
Hypercalcemia of malignancy presents with polyuria, constipation, confusion, and nausea (stones, bones, groans); when restoring cognition is a goal, use isotonic hydration plus a bisphosphonate or denosumab as renal function allows.
Metastatic spinal cord compression is back pain plus neurologic change; hospice-compatible treatment is dexamethasone and, when the patient can travel and wants function preserved, palliative radiation.
Neutropenic isolation belongs to disease-directed oncology. On hospice, infection, transfusion, radiation, and selected surgery follow comfort and stated goals, not an absolute neutrophil count.
Last updated: October 2026
Why cancer trajectories sit in Assessment and Planning
The Hospice and Palliative Credentialing Center ( HPCC ) Certified Hospice and Palliative Nurse (CHPN) examination is a 150-item RN specialty board. Domain 1, Patient Care: Assessment and Planning , contributes 25 scored items. Domain 1.C asks you to identify specific patterns of progression, complications, and treatment for life-limiting conditions. Cancer and hematologic disease still fill a large share of hospice censuses, so stems test whether you can name the curve, recognize the emergency, and match the intervention to goals of care —not whether you can run an inpatient oncology service.
Treat cancer as a family of trajectories, not one diagnosis. A CHPN item that only says “the patient has cancer” is incomplete until you know solid versus hematologic disease, recent disease-directed therapy, and whether the family still wants hospital rescue.
Solid-tumor versus hematologic curves
Solid tumors (lung, breast, colorectal, pancreas, prostate, and most other epithelial cancers) often follow the classic cancer curve: months of relatively preserved function, then a steep decline over days to a few weeks as tumor burden, anorexia-cachexia, and organ failure stack. Families who saw the patient walking last month are shocked by bedbound dying. Name that pattern early so the interdisciplinary team can time opioid planning, caregiver teaching, and visit frequency.
Hematologic malignancies —acute leukemias, aggressive lymphomas, multiple myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms—are less linear. A patient with myeloma may look stable on Wednesday and be in septic shock from neutropenia on Thursday. Blast crisis, catastrophic bleeding from thrombocytopenia, transfusion dependence, and tumor lysis syndrome (TLS) after cytotoxics make prognostication noisier. Indolent diseases such as chronic lymphocytic leukemia or low-grade lymphoma can look like frailty for years, then transform. Do not score a heme patient against a solid-tumor “last month was good” story.
Complication Hallmark the CHPN RN must catch Hospice-fit response when goals support comfort
Hypercalcemia of malignancy Polyuria, constipation, nausea, confusion (stones, bones, groans) Isotonic hydration; zoledronic acid, pamidronate, or denosumab if restoring cognition is a goal
Metastatic spinal cord compression Recumbent back pain, weakness, sensory level, retention, saddle anesthesia Dexamethasone; palliative radiation if travel and function goals allow
Superior vena cava syndrome Facial and arm edema, plethora, chest-wall collaterals, dyspnea Head elevation, steroids, radiation or stenting for choking relief
Malignant bowel obstruction Distention, vomiting, no stool or flatus in ovarian, colorectal, or gastric cancer Octreotide, dexamethasone, venting gastrostomy; surgery only if life-prolongation is still the goal
Pathologic fracture Sudden inability to bear weight after bone metastases Analgesia, radiation, selected orthopedic fixation
Tumor fever Fever after infection is reasonably excluded Acetaminophen or a nonsteroidal anti-inflammatory drug for comfort
Pancytopenia Fatigue, bleeding, infection risk from marrow replacement or prior therapy Transfuse for dyspnea or bleeding, not for a number; skip isolation theater
Tumor lysis syndrome Hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia, kidney injury after treatment of a high-burden proliferative tumor Recognize the emergency; hospitalize only if the patient still wants rescue
Hypercalcemia of malignancy
This is the metabolic emergency you will actually see on hospice. Humoral hypercalcemia from parathyroid hormone-related peptide is common in squamous lung, renal cell, and some breast cancers. Osteolytic hypercalcemia is common in myeloma and bone-metastatic breast cancer. Corrected calcium often exceeds 12 mg/dL before families call; severe cases exceed 14 mg/dL . When restoring thinking is a goal, give isotonic hydration first, then a bisphosphonate (zoledronic acid or pamidronate) or denosumab if renal impairment or prior bisphosphonate failure makes that the better choice. Calcitonin drops calcium faster but only for a day or two. If the goal is comfort dying and intravenous access is a burden, skip disease-directed calcium lowering and treat constipation, nausea, and confusion as comfort problems. The exam trap is transferring every high calcium to a hospital as if hospice had no other tools.
Spinal cord compression, SVC syndrome, obstruction, and fracture
Metastatic spinal cord compression is back pain plus a neurologic change until proven otherwise. Pain is often worse lying down. Weakness, a sensory level, urinary retention, constipation, and saddle anesthesia are late. Immediate dexamethasone , imaging if the patient would still accept radiation or surgery, and palliative radiation for radiosensitive disease (prostate, breast, myeloma, lymphoma) are the disease-directed package. On hospice, steroids plus bladder management and radiation only if the patient can travel and wants to preserve walking or continence. Surgery is for a selected single site, good enough performance status, and a goal of remaining ambulatory.
Superior vena cava (SVC) syndrome presents with facial and arm edema, plethora, dilated chest-wall collaterals, and dyspnea, classically in small-cell lung cancer and lymphoma. Head elevation, steroids, and palliative radiation or stenting can fit hospice when the goal is to sit up without choking.
Malignant bowel obstruction is common in ovarian, colorectal, and gastric cancer. Complete obstruction with ischemia is a surgical emergency only if life-prolongation is still the goal. Palliative packages include a time-limited nothing-by-mouth trial, a venting gastrostomy , octreotide to reduce secretions, dexamethasone for peri-tumor edema, and antiemetics. Do not keep a nasogastric tube indefinitely as treatment when the goal is a home death.
Pathologic fracture follows bone metastases (breast, prostate, lung, kidney, myeloma): sudden inability to bear weight, a rotated leg, or a snap with a transfer. Analgesia is never optional. Radiation, orthopedic fixation, and bone-modifying agents are goal-dependent.
Tumor fever, pancytopenia, TLS, and paraneoplastic syndromes
Tumor fever is a diagnosis of exclusion after infection is reasonably considered. Scheduled acetaminophen or a nonsteroidal drug can be comfort care. Do not start broad-spectrum antibiotics solely because the census sheet says cancer.
Pancytopenia from marrow replacement, prior chemotherapy, or myelodysplasia drives fatigue, bleeding, and infection risk. Hospice transfusion is a comfort intervention (dyspnea from anemia, bleeding from low platelets), not a number chase. Neutropenic precautions —protective isolation, visitor bans, raw-food rules—belong to disease-directed oncology. On hospice, the CHPN RN frames infection as a comfort decision: antipyretics, oral antibiotics if they reduce distressing fever, or no antimicrobials if the family has chosen a natural death.
TLS is more an acute-oncology emergency than a hospice daily event: hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia, and acute kidney injury after treatment of a high-burden, highly proliferative tumor (Burkitt lymphoma, acute lymphoblastic leukemia). You still need to recognize it so you do not miss a reversible catastrophe in a patient who still wants hospital care—and so you do not reflexively hospitalize a hospice patient whose stated goal is home dying after a last dose of cytotoxic therapy.
Paraneoplastic syndromes can disable a patient whose scan looks modest. Syndrome of inappropriate antidiuretic hormone (SIADH) from small-cell lung cancer causes euvolemic hyponatremia; treat confusion and seizures as comfort problems when fluid restriction no longer fits the home. Ectopic Cushing syndrome (also small-cell) produces hyperglycemia, hypertension, and proximal weakness. Paraneoplastic neuropathy and Lambert-Eaton myasthenic syndrome can be the reason function collapsed. Function, not tumor volume, drives the hospice conversation.
When palliative radiation or surgery still fits hospice
Hospice election generally means the patient forgoes therapy intended to cure or prolong life. Palliative radiation for painful bone metastases, bleeding, SVC syndrome, or cord compression, and selected surgery (venting gastrostomy, pathologic-fracture fixation, cord decompression) can still be appropriate when the intent is symptom relief, the burden is acceptable, and the program can arrange it. The CHPN RN coordinates with radiation oncology, surgery, and the hospice medical director. You do not order radiation in isolation, and you do not treat every hospital-based oncology protocol as forbidden or as mandatory.